Angela Koehler

Dr. Angela Koehler is a scientific advisor for Nested Therapeutics. She is currently the Kathleen and Curtis Marble Professor in the Department of Biological Engineering at MIT and an Associate Director of the David H. Koch Institute for Integrative Cancer Research at MIT. She is also a member of the MIT Center for Cancer Precision Medicine and an Institute Member of the Broad Institute. The Koehler Lab aims to innovate in the earliest stages of drug discovery by building chemical tools or technologies to assist in the process of target validation and by expanding the repertoire of protein targets that are considered to be druggable. Angela also serves as Faculty Co-Director of the High-Throughput Sciences Facility at the Koch Institute, Faculty Co-Director of the MIT Biomedical Engineering Undergraduate Program, and a member of the Chemists in Cancer Research steering committee for the American Association for Cancer Research. Her research and contributions to her field have earned her many awards, including Novartis Lectureship in Chemistry, the Ono Foundation Pharma Breakthrough Science Award, and recognition as a Genome Technology Young Investigator. She has also founded several biotechnology companies, including Ligon Discovery, Kronos Bio, and 76Bio. Angela received her Ph.D. in Chemistry from Harvard University and her B.A. in Biochemistry and Molecular Biology from Reed College.